Request Sample Inquiry
Diabetes Drugs Market

Diabetes Drugs Market

Diabetes Drugs Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

210

Base Year:

2024

Date

Oct - 2024

Format:

PDF XLS PPT

Report Code:

VMR-3023

Segments Covered
  • By Drug Class By Drug Class Insulin, GLP-1 Receptor Agonists, SGLT-2 Inhibitors, DPP-4 Inhibitors, Biguanides (Metformin), Others (Thiazolidinediones, Meglitinides)
  • By Diabetes Type By Diabetes Type Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
  • By Route of Administration By Route of Administration Oral, Injectable
  • By Distribution Channel By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2024
Forecast YearsForecast Years: 2025 - 2034
Historical YearsHistorical Years: 2019 - 2023
Revenue 2024Revenue 2024: USD 84.65 Billion
Revenue 2034Revenue 2034: USD 177.74 Billion
Revenue CAGRRevenue CAGR (2025 - 2034): 7.7%
Fastest Growing Region Fastest Growing Region (2025 - 2034) Asia Pacific
Largest Region Largest Region (2024): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Diabetes Drugs Market Segment Analysis

  • Diabetes Drugs Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Insulin
    • GLP-1 Receptor Agonists
    • SGLT-2 Inhibitors
    • DPP-4 Inhibitors
    • Biguanides (Metformin)
    • Others (Thiazolidinediones
    • Meglitinides)
  • Diabetes Drugs Diabetes Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Gestational Diabetes
  • Diabetes Drugs Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
    • Oral
    • Injectable
  • Diabetes Drugs Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Specialty Clinics
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Diabetes Drugs Market, by Drug Class
        • Insulin
        • GLP-1 Receptor Agonists
        • SGLT-2 Inhibitors
        • DPP-4 Inhibitors
        • Biguanides (Metformin)
        • Others (Thiazolidinediones
        • Meglitinides)
      • North America Diabetes Drugs Market, by Diabetes Type
        • Type 1 Diabetes
        • Type 2 Diabetes
        • Gestational Diabetes
      • North America Diabetes Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • North America Diabetes Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Specialty Clinics
      • U.S.
        • U.S. Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • U.S. Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • U.S. Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • U.S. Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Canada
        • Canada Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Canada Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Canada Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Canada Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Mexico
        • Mexico Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Mexico Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Mexico Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Mexico Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
    • Europe
      • Europe Diabetes Drugs Market, by Drug Class
        • Insulin
        • GLP-1 Receptor Agonists
        • SGLT-2 Inhibitors
        • DPP-4 Inhibitors
        • Biguanides (Metformin)
        • Others (Thiazolidinediones
        • Meglitinides)
      • Europe Diabetes Drugs Market, by Diabetes Type
        • Type 1 Diabetes
        • Type 2 Diabetes
        • Gestational Diabetes
      • Europe Diabetes Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • Europe Diabetes Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Specialty Clinics
      • U. K.
        • U.K. Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • U.K. Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • U.K. Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • U.K. Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • France
        • France Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • France Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • France Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • France Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Germany
        • Germany Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Germany Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Germany Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Germany Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Italy
        • Italy Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Italy Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Italy Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Italy Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Spain
        • Spain Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Spain Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Spain Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Spain Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Rest of Europe
        • Rest of Europe Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Rest of Europe Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Rest of Europe Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Rest of Europe Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
    • Asia Pacific
      • Asia Pacific Diabetes Drugs Market, by Drug Class
        • Insulin
        • GLP-1 Receptor Agonists
        • SGLT-2 Inhibitors
        • DPP-4 Inhibitors
        • Biguanides (Metformin)
        • Others (Thiazolidinediones
        • Meglitinides)
      • Asia Pacific Diabetes Drugs Market, by Diabetes Type
        • Type 1 Diabetes
        • Type 2 Diabetes
        • Gestational Diabetes
      • Asia Pacific Diabetes Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • Asia Pacific Diabetes Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Specialty Clinics
      • China
        • China Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • China Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • China Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • China Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Japan
        • Japan Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Japan Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Japan Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Japan Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Germany
        • Germany Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Germany Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Germany Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Germany Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • India
        • India Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • India Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • India Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • India Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • South Korea
        • South Korea Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • South Korea Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • South Korea Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • South Korea Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • South East Asia
        • South East Asia Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • South East Asia Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • South East Asia Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • South East Asia Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Rest of Asia Pacific
        • Rest of Asia Pacific Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Rest of Asia Pacific Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Rest of Asia Pacific Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Rest of Asia Pacific Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
    • Latin America
      • Latin America Diabetes Drugs Market, by Drug Class
        • Insulin
        • GLP-1 Receptor Agonists
        • SGLT-2 Inhibitors
        • DPP-4 Inhibitors
        • Biguanides (Metformin)
        • Others (Thiazolidinediones
        • Meglitinides)
      • Latin America Diabetes Drugs Market, by Diabetes Type
        • Type 1 Diabetes
        • Type 2 Diabetes
        • Gestational Diabetes
      • Latin America Diabetes Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • Latin America Diabetes Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Specialty Clinics
      • Brazil
        • Brazil Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Brazil Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Brazil Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Brazil Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Argentina
        • Argentina Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Argentina Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Argentina Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Argentina Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Rest of Latin America
        • Rest of Latin America Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Rest of Latin America Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Rest of Latin America Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Rest of Latin America Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
    • Middle East & Africa
      • Middle East & Africa Diabetes Drugs Market, by Drug Class
        • Insulin
        • GLP-1 Receptor Agonists
        • SGLT-2 Inhibitors
        • DPP-4 Inhibitors
        • Biguanides (Metformin)
        • Others (Thiazolidinediones
        • Meglitinides)
      • Middle East & Africa Diabetes Drugs Market, by Diabetes Type
        • Type 1 Diabetes
        • Type 2 Diabetes
        • Gestational Diabetes
      • Middle East & Africa Diabetes Drugs Market, by Route of Administration
        • Oral
        • Injectable
      • Middle East & Africa Diabetes Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Specialty Clinics
      • GCC Countries
        • GCC Countries Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • GCC Countries Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • GCC Countries Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • GCC Countries Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • South Africa
        • South Africa Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • South Africa Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • South Africa Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • South Africa Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Diabetes Drugs Market, by Drug Class
          • Insulin
          • GLP-1 Receptor Agonists
          • SGLT-2 Inhibitors
          • DPP-4 Inhibitors
          • Biguanides (Metformin)
          • Others (Thiazolidinediones
          • Meglitinides)
        • Rest of Middle East & Africa Diabetes Drugs Market, by Diabetes Type
          • Type 1 Diabetes
          • Type 2 Diabetes
          • Gestational Diabetes
        • Rest of Middle East & Africa Diabetes Drugs Market, by Route of Administration
          • Oral
          • Injectable
        • Rest of Middle East & Africa Diabetes Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retail Pharmacies
          • Online Pharmacies
          • Specialty Clinics
FAQ
Frequently Asked Question
  • The global Diabetes Drugs valued at USD 84.65 Billion in 2024 and is expected to reach USD 177.74 Billion in 2034 growing at a CAGR of 7.7%.

  • The prominent players in the market are Novo Nordisk, Sanofi, Bristol Myers Squibb, Eli Lilly and Company, AstraZeneca, Merck & Co., Johnson & Johnson, Pfizer, Novartis, Boehringer Ingelheim, AbbVie, Teva Pharmaceuticals, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan N.V. (now part of Viatris)..

  • The market is project to grow at a CAGR of 7.7% between 2025 and 2034.

  • The driving factors of the Diabetes Drugs include

  • North America was the leading regional segment of the Diabetes Drugs in 2024.